Scotiabank lowered the firm’s price target on UDR (UDR) to $48 from $49 and keeps a Sector Perform rating on the shares. Rental demand remains robust, which should persist into 2025 due to ...
Scotiabank raised the firm’s price target on BridgeBio (BBIO) to $52 from $49 and keeps an Outperform rating on the shares. The company’s earnings release reflects “stellar commercial momentum” in the ...
In terms of valuation, Goldman noted that Magna's shares are trading at 4.8 times the enterprise value to EBITDA (EV/EBITDA) based on Scotiabank (TSX:BNS)'s 2025 estimates, which is below the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results